New research from the Virginia Bioinformatics Institute (VBI) has proven that there are very specific changes in the genetic makeup of people suffering from cancer and those who don’t have cancer. The researchers from VBI have developed a new technology that catches these genetic changes, which help in differentiating cancer patients from healthy individuals. The [...]
MedTrust Online and Avantra Biosciences have entered into a partnership to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences’ revolutionary QPDx multiplex immunoassay system.
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth. Inhibition of these enzymes prevents prostate cancer cell growth in cultured cells. This knowledge can be used to identify different subtypes of prostate cancer and for designing targeted therapies for prostate cancer.
Researchers at MIT and Brigham and Women’s Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target. Using the new particles, the researchers were able to [...]
Another week, another nano-prefixed word to add to the lexicon: NanoPopcorn. This one comes courtesy of researchers at Jackson State University in Mississippi who created a popcorn-shaped nanoparticle that can perform three separate tasks. First, it can detect as few as 50 prostate cancer cells, then it switches into thermal scalpel mode to cook the [...]
There are many reasons cancer patients can dread chemotherapy. It might kill their cancer, but those who go through it often wonder if the cure is just as bad as the disease. Among the uncomfortable symptoms is chemotherapy-induced vomiting. Ahmedabad, India-based Lincoln Pharmaceuticals has been granted a patent for its nasal drug delivery system (NDDS) [...]
Eight months after Merck jumped into the driver’s seat to take control of Ariad’s late-stage cancer program ridaforolimus, the biotech is reporting that one of its Phase III study turned in statistically significant results. And the news quickly spurred a 36 percent increase in the biotech’s share price.
There are many possible ways to kill a cancer cell, and one of them is to cook them to death. There are nanoparticles worth their weight in gold to do just that. Researchers at the Niels Bohr Institute at the University of Copenhagen are experimenting with tiny gold particles’ ability to melt the lipid membranes [...]
It was Max Wicha of the University of Michigan who first identified breast cancer stem cells back in 2003. Now, Wicha and colleagues have identified a possible way to attack these cells, which are responsible for a tumor’s growth and spread.
Remarkable progress in understanding how stem cell biology works has been reported by a team of leading scientists, directed by experts at UC Santa Barbara. Stem cell biology is making waves around the world with great hope for the eventual repair of parts of the body. While many scientists see these breakthroughs as viable, there [...]
You are currently browsing the weblog archives for 'cancer' tag.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.
Biotech Trading Signals Pharma News Biotech News